ATK Biotech
ATK Biotech, officially known as Ahtiankai Biotech, is a leading player in the biotechnology industry, headquartered in China (CN). Founded in 2015, the company has rapidly established itself as a key innovator in the fields of genetic engineering and biopharmaceuticals, with significant operations across Asia and Europe. Specialising in advanced gene editing technologies and therapeutic solutions, ATK Biotech offers unique products that cater to both research and clinical applications. Their commitment to quality and innovation has positioned them as a trusted partner in the biotech community. Notable achievements include several successful collaborations with academic institutions and a growing portfolio of patented technologies, solidifying their market presence and reputation for excellence.
DitchCarbon Score
How does ATK Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Seasonings and Extracts industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ATK Biotech's score of 15 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ATK Biotech's reported carbon emissions
ATK Biotech, headquartered in CN, currently does not have available carbon emissions data for recent years, nor specific reduction targets or climate pledges outlined in their initiatives. Without concrete figures or commitments, it is challenging to assess their carbon footprint or climate strategy. However, the absence of data may indicate a need for enhanced transparency and accountability in their environmental practices. As the industry increasingly prioritises sustainability, ATK Biotech may benefit from establishing clear emissions reduction goals and aligning with recognised climate frameworks to demonstrate their commitment to mitigating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ATK Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
